Chiron Capital Management’s Evolus EOLS Stock Holding History

Chiron Capital Management’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,382	Closed	-$5K	–	185
2020 Q3	$5K	Buy	+1,382	New	+$5.05K	﹤0.01%	361

Other funds holding EOLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

AWH Capital Dallas, Texas $110M AUM 44.24% 1-Year Est. Return

Chiron Capital Management's EOLS Position: Q4 2020 in Review

Chiron Capital Management sold out of Evolus (EOLS) in Q4 2020, closing a stake of 1,382 shares — an estimated $5K sold.

Chiron Capital Management first reported a position in EOLS in Q3 2020 and held it in 1 quarter. The position peaked at $5K in Q3 2020. 85 funds tracked by Wall St. Rank hold EOLS as of Q4 2020.

Chiron Capital Management reported no remaining Evolus position as of Q4 2020 after selling out during the quarter.
Chiron Capital Management sold 1,382 Evolus shares in Q4 2020, an estimated $5K.
Chiron Capital Management first reported a position in Evolus in Q3 2020 and held it in 1 quarter.
Chiron Capital Management's Evolus position peaked at $5K in Q3 2020.
85 funds tracked by Wall St. Rank held Evolus as of Q4 2020.

Based on Chiron Capital Management's 13F filing for Q4 2020, filed 5 Mar 2021.